tradingkey.logo

Perceptive Capital Solutions Corp

PCSC

10.570USD

0.000
Horarios del mercado ETCotizaciones retrasadas 15 min
116.98MCap. mercado
44.92P/E TTM

Perceptive Capital Solutions Corp

10.570

0.000
Más Datos de Perceptive Capital Solutions Corp Compañía
Perceptive Capital Solutions Corp is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It has not selected any specific business combination target and has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. It may pursue an acquisition opportunity in any business, industry, sector or geographical location. It intends to focus on industries that complement its management team’s background, and to capitalize on the ability of its management team to identify and acquire a business, focusing on the healthcare or healthcare-related industries. In particular, the Company is targeting North American or European companies in the life sciences and medical technology sectors. The Company neither engaged in any operations nor generated any revenues.
Información de la empresa
Símbolo de cotizaciónPCSC
Nombre de la empresaPerceptive Capital Solutions Corp
Fecha de salida a bolsaJun 12, 2024
Director ejecutivoMr. Adam Stone
Número de empleados- -
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 12
Dirección51 Astor Place
CiudadNEW YORK
Bolsa de valoresNASDAQ Global Market Consolidated
PaísUnited States of America
Código postal10003
Teléfono12122842300
Sitio Web
Símbolo de cotizaciónPCSC
Fecha de salida a bolsaJun 12, 2024
Director ejecutivoMr. Adam Stone
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Mark C. Mckenna
Mr. Mark C. Mckenna
Independent Director Nominee
Independent Director Nominee
--
--
Dr. Kenneth Song, M.D.
Dr. Kenneth Song, M.D.
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Harlan W. Waksal, M.D.
Mr. Harlan W. Waksal, M.D.
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Joseph (Joe) Edelman
Mr. Joseph (Joe) Edelman
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Adam Stone
Mr. Adam Stone
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Sam M. (Sam) Cohn, CPA
Mr. Sam M. (Sam) Cohn, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Michael Altman
Mr. Michael Altman
Chief Business Officer and Director
Chief Business Officer and Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Mark C. Mckenna
Mr. Mark C. Mckenna
Independent Director Nominee
Independent Director Nominee
--
--
Dr. Kenneth Song, M.D.
Dr. Kenneth Song, M.D.
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Harlan W. Waksal, M.D.
Mr. Harlan W. Waksal, M.D.
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Joseph (Joe) Edelman
Mr. Joseph (Joe) Edelman
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Adam Stone
Mr. Adam Stone
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Sam M. (Sam) Cohn, CPA
Mr. Sam M. (Sam) Cohn, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Desglose de ingresos
Sin datos
Sin datos
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: mar., 13 de may
Actualizado: mar., 13 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
VR Adviser, LLC
8.42%
RA Capital Management, LP
8.42%
Adar1 Capital Management LLC
8.42%
Commodore Capital LP
8.42%
RTW Investments L.P.
8.33%
Other
58.00%
Accionistas
Accionistas
Proporción
VR Adviser, LLC
8.42%
RA Capital Management, LP
8.42%
Adar1 Capital Management LLC
8.42%
Commodore Capital LP
8.42%
RTW Investments L.P.
8.33%
Other
58.00%
Tipos de accionistas
Accionistas
Proporción
Hedge Fund
48.46%
Investment Advisor/Hedge Fund
20.21%
Venture Capital
16.83%
Investment Advisor
5.15%
Corporation
3.21%
Research Firm
1.95%
Pension Fund
1.76%
Other
2.42%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
45
8.70M
97.58%
-719.67K
2025Q1
45
8.73M
97.95%
-644.93K
2024Q4
41
8.68M
97.41%
+469.87K
2024Q3
37
8.32M
93.31%
-9.25K
2024Q2
34
8.36M
96.88%
+8.36M
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
VR Adviser, LLC
750.00K
8.42%
--
--
Mar 31, 2025
RA Capital Management, LP
750.00K
8.42%
--
--
Mar 31, 2025
Adar1 Capital Management LLC
750.00K
8.42%
--
--
Mar 31, 2025
Commodore Capital LP
750.00K
8.42%
--
--
Mar 31, 2025
RTW Investments L.P.
742.50K
8.33%
--
--
Mar 31, 2025
683 Capital Management LLC
500.00K
5.61%
--
--
Mar 31, 2025
Sculptor Capital Management, Inc
412.85K
4.63%
--
--
Mar 31, 2025
RiverNorth Capital Management LLC
381.54K
4.28%
+50.00K
+15.08%
Mar 31, 2025
Decagon Asset Management LLP
362.85K
4.07%
+62.85K
+20.95%
Mar 31, 2025
Affinity Asset Advisors LLC
350.00K
3.93%
--
--
Mar 31, 2025
Ver más
ETFs relacionados
Nombre
Proporción
Sin datos
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI